Pfizer’s Paxlovid was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.1 The drug consists of nirmatrelvir tablets — the antiviral component — and ritonavir tablets, which are intended to slow the breakdown of nirmatrelvir.2 What started out as a slow rollout — only 40,000 or fewer prescriptions were written for… Read More »
By Dr. Mercola If you think your birth control pill is the best pregnancy prevention tool there is, you may be surprised by new research looking into its failure rates. Compared to other forms of protection, the Pill failed miserably, which only adds to the myriad of reasons why you should heavily question its use.… Read More »
Dive Brief: A new report by the HHS Office of Inspector General indicated that inpatient hospital stays have become more expensive to the Medicare program, even before the COVID-19 pandemic began to severely disrupt the U.S. healthcare system a year ago. HHS OIG analyzed Medicare Part A claims for inpatient stays from fiscal year 2014… Read More »